[ORGANIZATION]
Intismeran
Featured in 2 tracked stories · first seen
Situations
Moderna and Merck melanoma vaccine clinical trials
3 clusters · 344 sources · last updated
Latest: Málaga hospital leads trial for personalized mRNA melanoma vaccine
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target
Also covered in
-
Moderna and Merck announce successful melanoma mRNA vaccine trials
[HEALTH] · 4 sources ·